Cargando…

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression

Detalles Bibliográficos
Autores principales:	Antin, C., Tauziède-Espariat, A., Debily, M.-A., Castel, D., Grill, J., Pagès, M., Ayrault, O., Chrétien, F., Gareton, A., Andreiuolo, F., Lechapt, E., Varlet, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643397/ https://www.ncbi.nlm.nih.gov/pubmed/33153494 http://dx.doi.org/10.1186/s40478-020-01056-8

Ejemplares similares

Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
por: Pratt, Drew, et al.
Publicado: (2020)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

DIPG-58. HISTONE H3 WILD-TYPE DIPG/DMG OVEREXPRESSING EZHIP EXTEND THE SPECTRUM OF DIFFUSE MIDLINE GLIOMAS WITH PRC2 INHIBITION BEYOND H3-K27M MUTATION
por: Castel, David, et al.
Publicado: (2020)

EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
por: Jenseit, Anne, et al.
Publicado: (2021)

Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
por: Alturkustani, Murad, et al.
Publicado: (2021)

PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism
por: Jain, Siddhant U., et al.
Publicado: (2019)

NF2 and ZFTA evaluation in the diagnostic algorithm of pediatric posterior fossa ependymoma with H3K27ME3 retained expression
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

EPEN-20. EZHIP/CATACOMB COOPERATES WITH PDGF-A AND p53 LOSS TO GENERATE A GENETICALLY ENGINEERED MOUSE MODEL FOR POSTERIOR FOSSA A EPENDYMOMA
por: Kagan, Emily, et al.
Publicado: (2020)

The pediatric supratentorial MYCN-amplified high-grade gliomas methylation class presents the same radiological, histopathological and molecular features as their pontine counterparts
por: Tauziède-Espariat, A., et al.
Publicado: (2020)

EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells
por: Ragazzini, Roberta, et al.
Publicado: (2019)

TBIO-09. EZHIP is not expressed within the developing mouse or human brain
por: Talal Younes, Subhi, et al.
Publicado: (2022)

An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
por: Tauziède-Espariat, A., et al.
Publicado: (2019)

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis
por: Mariet, Cassandra, et al.
Publicado: (2022)

Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
por: Pagès, Mélanie, et al.
Publicado: (2018)

EPEN-38. EZH2 INHIBITORY PROTEIN (EZHIP/Cxorf67) EXPRESSION IS HIGHLY CONCORDANT WITH H3K27me3 LOSS AND IS A PROMISING SURROGATE MARKER FOR POSTERIOR FOSSA TYPE A EPENDYMOMAS
por: Nambirajan, Aruna, et al.
Publicado: (2020)

The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases
por: Pagès, Mélanie, et al.
Publicado: (2022)

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors
por: Tauziède‐Espariat, Arnault, et al.
Publicado: (2021)

The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population
por: Gareton, Albane, et al.
Publicado: (2019)

Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion
por: Pages, Melanie, et al.
Publicado: (2015)

Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD)
por: Briggs, Mayen, et al.
Publicado: (2022)

Prognostic relevance of adding MRI data to WHO 2016 and cIMPACT‐NOW updates for diffuse astrocytic tumors in adults. Working toward the extended use of MRI data in integrated glioma diagnosis
por: Roux, Alexandre, et al.
Publicado: (2021)

Pediatric methylation class HGNET-MN1: unresolved issues with terminology and grading
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2019)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

Disseminated diffuse midline gliomas, H3K27-altered mimicking diffuse leptomeningeal glioneuronal tumors: a diagnostical challenge!
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

DIPG-38. PATIENT-DERIVED THREE-DIMENSIONAL AVATARS REVEAL CELL-AUTONOMOUS MECHANISMS DRIVING INVASION AND METASTATIC PROGRESSION IN DIFFUSE MIDLINE GLIOMAS
por: Bruschi, Marco, et al.
Publicado: (2023)

Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
por: Guerrini-Rousseau, Léa, et al.
Publicado: (2023)

The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of “CNS tumors with BCOR internal tandem duplication”
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2020)

Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study
por: Chapman, Rebecca J, et al.
Publicado: (2023)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

Treatment implications of posterior fossa ependymoma subgroups
por: Ramaswamy, Vijay, et al.
Publicado: (2016)

DIPG-43. CLINICAL AND MOLECULAR CHARACTERISTIC OF A NEW SUBTYPE OF DMG, H3K27-ALTERED WITH MAPK-ACTIVATING CO-DRIVER MUTATIONS
por: Auffret, Lucie, et al.
Publicado: (2023)

A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Thoracic laminectomy and midline myelotomy for resection of a spinal ependymoma
por: Scherschinski, Lea, et al.
Publicado: (2023)

Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2023)

EPEN-26. NON-CANONICAL NF-κB SIGNALING DRIVES MESENCHYMAL EPENDYMAL CELL SUBPOPULATION IN PFA EPENDYMOMA
por: Griesinger, Andrea, et al.
Publicado: (2020)

Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
por: Pun, Matthew, et al.
Publicado: (2023)

Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications
por: von Hoff, Katja, et al.
Publicado: (2008)

The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profile
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
por: Wu, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ndrkht4j5kkfnehlv4g07u9gam